Enterprise Value
$235.03 B
+$1.86 B+0.80%
Thu, 28 Nov 2024 00:29:58 GMT
Summary:
AstraZeneca enterprise value is currently $235.03 billion, with a rise of +$1.86 billion (+0.80%) during the most recent trading day. Over the past year, it has increased by +$14.02 billion (+6.35%). AZN enterprise value is now -21.52% below its all-time high of $299.47 billion.AZN Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Enterprise Value Performance
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +0.8% | +0.9% | +0.9% |
| 1 m1 month | -9.2% | -10.3% | -10.3% |
| 3 m3 months | -20.6% | -22.7% | -22.7% |
| 6 m6 months | -12.7% | -14.2% | -14.2% |
| ytdytd | +1.2% | -0.6% | -0.6% |
| 1 y1 year | +6.3% | +5.6% | +5.5% |
| 5 y5 years | +65.3% | +62.8% | +37.7% |
AZN Enterprise Value High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $262 B | -10.4% | $223 B | +5.2% |
| 3 m | 3 months | $299 B | -21.5% | $223 B | +5.2% |
| 6 m | 6 months | $299 B | -21.5% | $223 B | +5.2% |
| 1 y | 1 year | $299 B | -21.5% | $212 B | +10.7% |
| 3 y | 3 years | $299 B | -21.5% | $189 B | +24.3% |
| 5 y | 5 years | $299 B | -21.5% | $112 B | +109.8% |
| alltime | all time | $299 B | -21.5% | $11 B | +2114.8% |
AstraZeneca Enterprise Value History
| Date | Value |
|---|---|
| 2024 | $235.03 B(+1.2%) |
| 2023 | $232.30 B(-0.4%) |
| 2022 | $233.22 B(+13.8%) |
| 2021 | $204.96 B(+42.5%) |
| 2020 | $143.79 B(+0.1%) |
| 2019 | $143.71 B(+29.9%) |
| 2018 | $110.61 B(+8.1%) |
| 2017 | $102.36 B(+26.3%) |
| 2016 | $81.01 B(-14.5%) |
| 2015 | $94.76 B(+1.3%) |
| 2014 | $93.50 B(+23.2%) |
| 2013 | $75.92 B(+22.8%) |
| 2012 | $61.85 B(-0.4%) |
| 2011 | $62.12 B(-2.3%) |
| 2010 | $63.61 B(-8.2%) |
| 2009 | $69.25 B(+23.1%) |
| Date | Value |
|---|---|
| 2008 | $56.25 B(-21.5%) |
| 2007 | $71.68 B(-5.9%) |
| 2006 | $76.15 B(+2.5%) |
| 2005 | $74.27 B(+23.7%) |
| 2004 | $60.04 B(-26.4%) |
| 2003 | $81.63 B(+35.1%) |
| 2002 | $60.43 B(-25.9%) |
| 2001 | $81.58 B(-10.1%) |
| 2000 | $90.77 B(+21.3%) |
| 1999 | $74.84 B(+84.2%) |
| 1998 | $40.63 B(+16.6%) |
| 1997 | $34.84 B(+27.5%) |
| 1996 | $27.32 B(+40.6%) |
| 1995 | $19.44 B(+46.4%) |
| 1994 | $13.28 B(+8.6%) |
| 1993 | $12.23 B |
FAQ
- What is AstraZeneca enterprise value?
- What is the all time high enterprise value for AstraZeneca?
- What is AZN enterprise value year-to-date change?
- What is AstraZeneca enterprise value year-on-year change?
What is AstraZeneca enterprise value?
The current enterprise value of AZN is $235.03 B
What is the all time high enterprise value for AstraZeneca?
AstraZeneca all-time high enterprise value is $299.47 B
What is AZN enterprise value year-to-date change?
AstraZeneca enterprise value has changed by +$2.73 B (+1.18%) since the beginning of the year
What is AstraZeneca enterprise value year-on-year change?
Over the past year, AZN enterprise value has changed by +$14.02 B (+6.35%)